Another EoE firm abandons ‘burdensome’ NASDAQ
0 Comments Published by claudia May 29th, 2007 in News, SOX, Europe, Company News, Accounting rules, Sarbox Tags: corporate accounting scandals, enron scandal, european firms, healthcare company, nasdaq stock market, sarbanes oxley act, stringent laws, us federal government.The Sarbanes-Oxley Act, passed by the US Federal Government in response to the Enron scandal in 2002 has caused BioProgress to delist from NASDAQ for the second time, adding to the register of European firms fleeing the US market.
Cambridge-based specialty pharma and healthcare company, BioProgress has announced its intention to delist from the NASDAQ stock market on June 18, as a result of the limited benefits of trading on the American market becoming outweighed by the cost of adhering to the stringent laws instituted because of large scale corporate accounting scandals.
BusinessWeekly.co.uk: Another EoE firm abandons ‘burdensome’ NASDAQ
EMail This |
Print This Post |
Search
About
You are currently browsing the SOX Center weblog archives for us federal government.
Categories
- Accounting rules (97)
- As2 (1)
- AS5 (4)
- Asia (21)
- Company News (33)
- Conferences (8)
- coso (1)
- Europe (41)
- FEI (2)
- M&A (3)
- News (151)
- North America (124)
- paper (8)
- PCAOB (25)
- Sarbox (75)
- SEC (98)
- Section 404 (122)
- small business (23)
- SOX (228)
- SOX Automations (3)
- Study (15)
- Uncategorized (21)
- White paper (2)
Highest Rated Entries




(5 out of 5)



(5 out of 5)



(5 out of 5)



(5 out of 5)



(5 out of 5)



(5 out of 5)



(5 out of 5)



(5 out of 5)



(5 out of 5)



(5 out of 5)
EMail This







